Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
Annals of Translational Medicine|August 25, 2021
Preclinical carotid atherosclerosis as an indicator of polyvascular disease: a narrative reviewPavel Poredos, Mateja K JezovnikSeminars in Thrombosis and Hemostasis|December 27, 2011
Dyslipidemia, statins, and venous thromboembolismPavel Poredos, Mateja Kaja JezovnikJournal of Atherosclerosis and Thrombosis|September 14, 2012
Testing endothelial function and its clinical relevancePavel Poredos, Mateja Kaja JezovnikHeart and Vessels|January 27, 2011
In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunctionPavel Poredos, Mateja Kaja JezovnikInternational Journal of Molecular Sciences|June 30, 2015
Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?Pavel Poredos, Mateja Kaja JezovnikCurrent Drug Targets|May 19, 2015
Deep Vein Thrombosis and Pulmonary Embolism in the Apixaban Era: From Bench to BedsidePavel Poredos, Mateja Kaja JezovnikCurrent Vascular Pharmacology|July 1, 2016
The Role of Inflammatory Biomarkers in the Detection and Therapy of Atherosclerotic DiseasePavel Poredos, Mateja K JezovnikVASA. Zeitschrift Fur Gefasskrankheiten|March 15, 2013
Is aspirin still the drug of choice for management of patients with peripheral arterial disease?Pavel Poredos, Mateja K JezovnikJournal of Atherosclerosis and Thrombosis|January 28, 2010
Idiopathic venous thrombosis is associated with preclinical atherosclerosisMateja Kaja Jezovnik, Pavel Poredos, Lara LusaClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 25, 2016
Patients With a History of Idiopathic Deep Venous Thrombosis Have Long-Term Increased Levels of Inflammatory Markers and Markers of Endothelial DamageMateja Kaja Jezovnik, Jawed Fareed, Pavel PoredosPageof 10